These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 18720690

  • 1. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
    Buell C, Koo J.
    J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
    [Abstract] [Full Text] [Related]

  • 2. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.
    Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
    [Abstract] [Full Text] [Related]

  • 3. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jan; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 4. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
    Hrvacević R, Ignjatović Lj, Vavić N, Dimitrijević J, Drasković-Pavlović B, Dujić A, Elaković D, Kronja G, Marić M.
    Vojnosanit Pregl; 2001 Oct; 58(2):157-60. PubMed ID: 11475669
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
    Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
    Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
    [Abstract] [Full Text] [Related]

  • 9. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J.
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil.
    Zwerner J, Fiorentino D.
    Dermatol Ther; 2007 Nov; 20(4):229-38. PubMed ID: 17970888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).
    Budde K, Knoll G, Curtis J, Chan L, Pohanka E, Gentil M, Seifu Y, Marrast AC, Neumayer HH, ERL B302 Study Group.
    Clin Nephrol; 2006 Aug; 66(2):103-11. PubMed ID: 16939066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T, Reis A, Kutkuhn B, Voiculescu A, Sundmacher R.
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 19. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S, Daswani A, Takemoto SK.
    Transplantation; 2003 Jul 15; 76(1):10-5. PubMed ID: 12865780
    [Abstract] [Full Text] [Related]

  • 20. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC, Morris-Jones R, Powles AV, Fry L.
    Br J Dermatol; 2000 Aug 15; 143(2):405-7. PubMed ID: 10951153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.